Emergent BioSolutions Receives $16.7M Contract Option To Continue Development Collaboration With BARDA On Ebanga Treatment For Ebola

BenzingaJan 13 22:28

Express News | Emergent BioSolutions Receives Contract Option Valued at Approximately $16.7 Million to Continue Development Collaboration With Barda on Ebanga™ (Ansuvimab-Zykl) Treatment for Ebola

BreakingsJan 13 22:27

Emergent BioSolutions Receives Contract Option Valued at Approximately $16.7 Million to Continue Development Collaboration With BARDA on Ebanga (Ansuvimab-zykl) Treatment for Ebola

GlobeNewswireJan 13 22:27

H.C. Wainwright Maintains Emergent BioSolutions(EBS.US) With Buy Rating, Maintains Target Price $15

Futu NewsJan 10 19:34 · Ratings

Emergent BioSolutions Receives $20 Million Contract to Supply Anthrax Vaccine to US Military

MT NewswiresJan 9 00:27

Emergent BioSolutions to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025

GlobeNewswireJan 8 20:45